Novo Shanti Gopal Health Care Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 14-12-2024
- Paid Up Capital ₹ 1.83 Cr
as on 14-12-2024
- Company Age 66 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 6.70 M
as on 14-12-2024
- Revenue -42.25%
(FY 2020)
- Profit 106.06%
(FY 2020)
- Ebitda -7.95%
(FY 2020)
- Net Worth 37.07%
(FY 2020)
- Total Assets 34.68%
(FY 2020)
About Novo Shanti Gopal Health Care
The Corporate was formerly known as Novo Pharmaceuticals Pvt Ltd. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.83 Cr.
The company has closed loans amounting to ₹6.70 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Ashok Patnaik, Sreejoy Patnaik, and Swarnav Patnaik serve as directors at the Company.
- CIN/LLPIN
U85195OR1958PTC000343
- Company No.
000343
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Apr 1958
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Cuttack
Industry
Company Details
- Location
Cuttack, Odisha, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Novo Shanti Gopal Health Care?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashok Patnaik  | Director | 01-Jan-1975 | Current |
| Sreejoy Patnaik | Director | 17-Jun-2016 | Current |
| Swarnav Patnaik | Director | 24-Feb-2012 | Current |
Financial Performance of Novo Shanti Gopal Health Care.
Novo Shanti Gopal Health Care Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 42.25% decrease. The company also saw a substantial improvement in profitability, with a 106.06% increase in profit. The company's net worth Soared by an impressive increase of 37.07%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Novo Shanti Gopal Health Care?
In 2020, Novo Shanti Gopal Health Care had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Raass Multi-Speciality Hospital Private LimitedActive 11 years 2 months
Sreejoy Patnaik is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 07 Mar 2006 | ₹5.90 M | Satisfied |
State Bank Of India Creation Date: 03 Jul 1995 | ₹0.80 M | Satisfied |
How Many Employees Work at Novo Shanti Gopal Health Care?
Unlock and access historical data on people associated with Novo Shanti Gopal Health Care, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Novo Shanti Gopal Health Care, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Novo Shanti Gopal Health Care's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
